SI-BONE is a medical device company. Co. has a proprietary minimally invasive surgical implant system, which it calls iFuse, to address sacroiliac joint dysfunction and degeneration, adult deformity, pelvic ring traumatic fractures. Co.'s iFuse Implant System includes a series of patented triangular implants and the instruments Co. has developed to enable surgeons to perform the procedures using different surgical approaches for different indications. Co. has introduced iFuse-3D, its other implant. This patented titanium implant combines the triangular cross-section of the iFuse Classic implant with the proprietary 3D-printed porous surface and a fenestrated design. The SIBN stock yearly return is shown above.
The yearly return on the SIBN stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2022 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the SIBN annual return calculation with any dividends reinvested as applicable (on ex-dates).
|